ISCOMs and immunostimulation with viral antigensHOGLUND, S; DALSGAARD, K; LOVGREN, K et al.Sub-cellular Biochemistry. 1989, Vol 15, pp 39-68, issn 0096-8757Article

Cytotoxic T cell polyepitope vaccines delivered by ISCOMsLE, Thuy T. T; DRANE, Debbie; MALLIAROS, Jim et al.Vaccine. 2001, Vol 19, Num 32, pp 4669-4675, issn 0264-410XArticle

A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) virusesRIMMELZWAAN, G. F; BAARS, M; VAN AMERONGEN, G et al.Vaccine. 2001, Vol 20, Num 1-2, pp 158-163, issn 0264-410XArticle

Liposomes and ISCOMsKERSTEN, Gideon F. A; CROMMELIN, Daan J. A.Vaccine. 2003, Vol 21, Num 9-10, pp 915-920, issn 0264-410X, 6 p.Conference Paper

Rinderpest virus (RPV) ISCOM vaccine induces protection in cattle against virulent RPV challengeKAMATA, Hiroshi; OHISHI, Kazue; HULSKOTTE, Ellena et al.Vaccine. 2001, Vol 19, Num 25-26, pp 3355-3359, issn 0264-410XArticle

Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporationANDERSSON, C; SANDBERG, L; WERNERUS, H et al.Journal of immunological methods. 2000, Vol 238, Num 1-2, pp 181-193, issn 0022-1759Article

Biochemical characteization of herpes simplex virus type-1-immunostimulating complexes (ISCOMs) : a multi-glycoprotein structureERTURK, M; JENNINGS, R; PHILLPOTTS, R. J et al.Vaccine. 1991, Vol 9, Num 9, pp 668-674, issn 0264-410XArticle

Evaluation of ISCOMATRIX™ and ISCOM™ vaccines for immunisation against Helicobacter pyloriSKENE, Caroline D; DOIDGE, Christopher; SUTTON, Philip et al.Vaccine. 2008, Vol 26, Num 31, pp 3880-3884, issn 0264-410X, 5 p.Article

Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccineAGUILA, Antonio; DONACHIE, Anne M; PEYRE, Marisa et al.Vaccine. 2006, Vol 24, Num 24, pp 5201-5210, issn 0264-410X, 10 p.Article

Bovine respiratory syncytial virus ISCOMs: protection in the presence of maternal antibodiesHÄGGLUND, Sara; HU, Ke-Fei; LARSEN, Lars Erik et al.Vaccine. 2004, Vol 23, Num 5, pp 646-655, issn 0264-410X, 10 p.Article

Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virusCROUCH, C. F; DALY, J; HANNANT, D et al.Vaccine. 2004, Vol 23, Num 3, pp 418-425, issn 0264-410X, 8 p.Article

ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responsesPEARSE, M. J; DRANE, D.Vaccine. 2004, Vol 22, Num 19, pp 2391-2395, issn 0264-410X, 5 p.Conference Paper

Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulationsPINITKIATISAKUL, Sunan; FRIEDMAN, Mikaela; WIKMAN, Maria et al.Vaccine. 2007, Vol 25, Num 18, pp 3658-3668, issn 0264-410X, 11 p.Article

Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscomsLARSSON, M; LÖVGREN, K; MOREIN, B et al.Journal of immunological methods. 1993, Vol 162, Num 2, pp 257-260, issn 0022-1759Article

Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccineCOULTER, Alan; HARRIS, Rodney; DAVIS, Roslyn et al.Vaccine. 2003, Vol 21, Num 9-10, pp 946-949, issn 0264-410X, 4 p.Conference Paper

Induction of virus-specific immunity by iscomsOSTERHAUS, A. D. M. E; RIMMELZWAAN, G. F.Developments in biological standardization. 1998, Num 92, pp 49-58, issn 0301-5149Conference Paper

Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensisGOLOVLIOV, I; ERICSSON, M; AKERBLOM, L et al.Vaccine. 1995, Vol 13, Num 3, pp 261-267, issn 0264-410XArticle

Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccinesMUMFORD, J. A; JESSETT, D; DUNLEAVY, U et al.Vaccine. 1994, Vol 12, Num 9, pp 857-863, issn 0264-410XArticle

Conjugation of synthetic peptides to carrier iscoms : factors affecting the immunogenicity of the conjugateLÖVGREN, K; LARSON, M.Journal of immunological methods. 1994, Vol 173, Num 2, pp 237-243, issn 0022-1759Article

Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leucocytesWATSON, D. L; WATSON, N. A; FOSSUM, C et al.Microbiology and immunology. 1992, Vol 36, Num 2, pp 199-203, issn 0385-5600Article

The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gapHELDENS, J. G. M; POUWELS, H. G. W; DERKS, C. G. G et al.Vaccine. 2009, Vol 27, Num 40, pp 5530-5537, issn 0264-410X, 8 p.Article

Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in catsHUISMAN, Willem; SCHRAUWEN, Eefje J. A; PAS, Suzan D et al.Vaccine. 2008, Vol 26, Num 21, pp 2553-2561, issn 0264-410X, 9 p.Article

Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infectionREGNER, Matthias; CULLEY, Fiona; FONTANNAZ, Paola et al.Microbes and infection. 2004, Vol 6, Num 7, pp 666-675, issn 1286-4579, 10 p.Article

Effect of priming on subsequent response to inactivated influenza vaccinePOTTER, C. W; JENNINGS, R.Vaccine. 2003, Vol 21, Num 9-10, pp 940-945, issn 0264-410X, 6 p.Conference Paper

Iscom, a delivery system for parenteral and mucosal vaccinationMOREIN, B; VILLACRES-ERIKSSON, M; LÖVGREN-BENGTSSON, K et al.Developments in biological standardization. 1998, Num 92, pp 33-39, issn 0301-5149Conference Paper